Skip to content

Clinicare Shops

Active
Private limited companyfounded 20215 yrs activeOude Zandstraat(BEV) 28, 9120 Beveren-Kruibeke-Zwijndrecht, BelgiumKBO/BCE: BE 0760.798.516

Clinicare Shops has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €217k and a net result of €817. Equity is shrinking by ~7.9% per year across the filed fiscal years. Its solvency ranks better than 82% of 18281 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 1.5% (low).

Checked score

Score 2025
74 / 100
Healthy
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability55▲+50
Solvency98▲+3
Growth58=
Track record94
Bankruptcy probability, 12 months
1.5% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €16k at 30 days acceptable
Liquidity ample (current ratio 3.6 against 3.36 in 2024; short-term debt: 26% and cash: 28% of total assets), and 27.1% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 5 years 0 10 y
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
72.9%
Return on assets
0.3%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 20-07-2026, 11 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
11 d early
2024
16 d early
2023
on the day
2022
71 d late
2021
31 d late
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
23-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€217k▲ 0.4%
2024 · €216k
2021: €284k 2022: €335k 2023: €251k 2024: €216k
2021 → 2025
Total assets
€297k▼ 3.1%
2024 · €307k
2021: €616k 2022: €655k 2023: €473k 2024: €307k
2021 → 2025
Net result
€817
2024 · €-35k
2021: €-47k 2022: €51k 2023: €-84k 2024: €-35k
2021 → 2025
Working capital
€201k▲ 3.0%
2024 · €196k
2021: €251k 2022: €288k 2023: €219k 2024: €196k
2021 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€284k-€335k▲ 17.8%€251k▼ 25.0%€216k▼ 13.9%€217k▲ 0.4%
Operating result€-47k-€52k€-80k€-28k▲ 65.4%€4k
Net result€-47k-€51k€-84k€-35k▲ 58.3%€817
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
€-100k€-50k€0€50kOperating result 2021: €-47k€-47kNet result 2021: €-47k€-47kOperating result 2022: €52k€52kNet result 2022: €51k€51kOperating result 2023: €-80k€-80kNet result 2023: €-84k€-84kOperating result 2024: €-28k€-28kNet result 2024: €-35k€-35kOperating result 2025: €4k€4kNet result 2025: €817€81720212022202320242025
The operating result returns to profit in 2025: €4k after a loss of €28k in 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €297k
Fixed assets €19k▼ 35.1%
Current assets €279k▲ 0.2%
Equity and liabilities €297k
Equity €217k▲ 0.4%
Debt €81k▼ 11.3%
The debt ratio falls from 29.6% to 27.1%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€14k
2024 · €-16k
Cash flow
€11k
2024 · €-23k
Solvency
72.9%
2024 · 70.4%
Current ratio
3.60
2024 · 3.36
Quick ratio
2.80
2024 · 2.13
Debt / equity
0.37
2024 · 0.42
ROE
0.4%
2024 · -16.2%
ROA
0.3%
2024 · -11.4%
Interest coverage
4.35
2024 · -2.06
Debt
€81k
2024 · €91k
Debt ≤ 1 year
€77k
2024 · €83k
Income taxes
€174
2024 · €136
Staff costs
€26k
2024 · €12k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€307k€297k
Fixed assets21/28€29k€19k
Intangible fixed assets21€13k€6k
Tangible fixed assets22/27€16k€13k
Plant, machinery and equipment23€3k€2k
Furniture and vehicles24€4k€3k
Other tangible fixed assets26€9k€8k
Financial fixed assets28€185€185=
Current assets29/58€278k€279k
Stocks and contracts in progress3€102k€62k
Stocks30/36€102k€62k
Amounts receivable within one year40/41€133k€134k
Trade receivables40€16k€10k
Other amounts receivable41€117k€124k
Cash at bank and in hand54/58€43k€83k
Deferred charges and accrued income490/1€0€177
Equity and liabilities
Total equity and liabilities10/49€307k€297k
Equity10/15€216k€217k
Contributions10/11€4k€4k=
Reserves13€212k€213k
Non-distributable reserves130/1€592€592=
Reserves not available under the articles1311€592€592=
Distributable reserves133€212k€212k
Amounts payable17/49€91k€81k
Amounts payable within one year42/48€83k€77k
Current portion of amounts payable after more than one year42€0-
Financial debts43€0-
Credit institutions430/8€0-
Trade debts44€9k€12k
Suppliers440/4€9k€12k
Taxes, remuneration and social security45€11k€4k
Taxes450/3€10k€145
Remuneration and social security454/9€1k€4k
Other amounts payable47/48€63k€61k
Accrued charges and deferred income492/3€8k€3k
Income statement Code20242025
Non-recurring operating income76A€0-
Remuneration, social security and pensions62€12k€26k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€12k€10k
Other operating charges640/8€3k€2k
Gross operating margin9900€-682€42k
Operating profit (loss)9901€-28k€4k
Financial income75/76B€757€547
Recurring financial income75€757€547
Financial charges65/66B€8k€3k
Recurring financial charges65€8k€3k
Profit (loss) for the period before taxes9903€-35k€991
Income taxes67/77€136€174
Profit (loss) for the period9904€-35k€817
Profit (loss) for the period to be appropriated9905€-35k€817
Appropriation of the result
Profit (loss) to be appropriated9906€-35k€817
Transfer from equity791/2€35k€0
Transfer to equity691/2-€817
To other reserves6921-€817

The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
20-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial Back to profitnet €817
Net result €817 after 2 loss-making years.
15-07
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
31-07
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial Weakest financial yearnet €-84k ▼265%
Net result drops to €-84k, the lowest in the series; recovery starts the following year.
10-10
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema · 71 days late
2022
31-12
Financial Back to profitnet €51k
Net result €51k after one loss-making year.
31-08
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Beveren-Kruibeke-Zwijndrecht · 1 establishment unit since 2021
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Oude Zandstraat(BEV) 289120 Beveren-Kruibeke-Zwijndrecht
Ground area
90 m²
Parcel 46502D0060/00C000, Flanders. Linked by address, not a title deed.
1 establishment unit
Clinicare Shops
Oude Zandstraat(BEV) 28, 9120 Beveren-Kruibeke-ZwijndrechtWholesale of pharmaceutical and medical goods
since 20212.313.102.679
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
46502D0060/00C000 Flanders 90 m² - -
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Public money · subsidies and aid

Flemish government

2025 · 1 entry · 2,000 EUR awarded · 2,000 EUR paid
Year Entries awardedpaid
2025 1 2,000 EUR2,000 EUR
Schemes
Hinderpremie bij openbare werken
1 entry · 2,000 EUR · 2,000 EUR paid · Fonds voor Innoveren en Ondernemen

Similar companies · same sector, comparable size

Of 1,070 companies in sector 47741 we hold annual accounts for 644. 491 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded04-01-2021
Fiscal year end31-12
Activities, NACEBEL
47740Retail trade
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
Sources
Crossroads Bank for EnterprisesNational Bank · 5 filingsAddress and cadastre registers

Data from official sources, last processed on 22-09-2026. Scores and ratios are computed by Checked and are not a credit decision.